Enasidenib (mesylate) (Standard)
Enasidenib (mesylate) (Standard) is the analytical standard of Enasidenib (mesylate) . This product is intended for research and analytical applications. Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes.
Product Specifications
CAS Number
1650550-25-6
UNSPSC
12352100
Target
Isocitrate Dehydrogenase (IDH) ; Reference Standards
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Cancer
Smiles
CS(=O)(O)=O.CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1
Molecular Formula
C20H21F6N7O4S
Molecular Weight
569.48
References & Citations
[1]Exploring the Pathway: IDH Mutations and Metabolic Dysregulation in Cancer Cells: A Novel Therapeutic Target. MAY 29, 2015|[2]Alan H. Shih, et al. AG-221, a Small Molecule Mutant IDH2 Inhibitor, Remodels the Epigenetic State of IDH2-Mutant Cells and Induces Alterations in Self-Renewal/Differentiation in IDH2-Mutant AML Model in Vivo. Blood 2014 124:437.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681925-100 1x 100 µL
P53 Tumor Suppressor Protein (PCRP-TP53-1F7), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940563-100 1x 100 µL
Cytokeratin 18 (DE-K18), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040520-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (MUC1/520), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details